Ayres K, Sklar R, Larson K, Lindgren V, Strauss B
Mol Cell Biol. 1982 Aug;2(8):904-13. doi: 10.1128/mcb.2.8.904-913.1982.
Hybrids were made between a ouabain-resistant, thioguanine-resistant human lymphoma line able to remove O6-methylguanine from its DNA (Mex+) and human lymphoblastoid lines deficient in this capability (Mex-). The formation of hybrids was confirmed by chromosomal analysis. Hybrid cells had an O6-methylguanine removal capacity per mole of guanine about one third to one half that of the Mex+ parents, i.e., about the same per cell. Cell hybrids removed the same amount of the alkylation adduct 3-methyladenine as did their parents per mole of guanine, i.e., about twice as much per cell. Although the cell hybrids had intermediate resistance to the cytotoxic action of N-methyl-N'-nitro-N-nitrosoguanidine used to induce O6-methylguanine and 3-methyladenine, there is evidence that the ability to remove O6-methylguanine and resistance to the cytotoxic effect of N-methyl-N'-nitro-N-nitrosoguanidine are dissociable characteristics.
将一种对哇巴因耐药、对硫代鸟嘌呤耐药且能够从其DNA中去除O6-甲基鸟嘌呤的人淋巴瘤细胞系(Mex+)与缺乏这种能力的人淋巴母细胞系(Mex-)进行杂交。通过染色体分析证实了杂交体的形成。杂交细胞每摩尔鸟嘌呤的O6-甲基鸟嘌呤去除能力约为Mex+亲本的三分之一到二分之一,即每个细胞的去除能力大致相同。细胞杂交体每摩尔鸟嘌呤去除的烷基化加合物3-甲基腺嘌呤的量与其亲本相同,即每个细胞的去除量约为亲本的两倍。尽管细胞杂交体对用于诱导O6-甲基鸟嘌呤和3-甲基腺嘌呤的N-甲基-N'-硝基-N-亚硝基胍的细胞毒性作用具有中等抗性,但有证据表明,去除O6-甲基鸟嘌呤的能力与对N-甲基-N'-硝基-N-亚硝基胍细胞毒性作用的抗性是可分离的特征。